Weekly Shot Of New Drug Hailed As Functional Cure For Hep B

Weekly Shot Of New Drug Hailed As Functional Cure For Hep B Scientists found that bepirovirsen prevents the virus from replicating in patients with chronic hepatitis B infections, allowing the immune system to attack. An FDA decision about whether Ionis Pharmaceuticals may market the drug in the U.S. is expected in late October, The New York Times reports. https://kffhealthnews.org/morning-breakout/top-3-pub-health/